Organigram (NASDAQ:OGI) Posts Earnings Results, Misses Estimates By $0.01 EPS

Organigram (NASDAQ:OGI) announced its quarterly earnings results on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01), Zacks reports. Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Organigram Stock Up 7.5 %

OGI stock opened at $1.73 on Wednesday. The company’s fifty day simple moving average is $1.63 and its 200 day simple moving average is $1.68. Organigram has a 12-month low of $1.21 and a 12-month high of $2.91. The firm has a market cap of $218.25 million, a price-to-earnings ratio of -3.83 and a beta of 1.02.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.